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Weanling male Sprague-Dawley rats were randomly fed three different diets (n=8 per
group), a control diet (AIN '93) (C), a blueberry diet (B) for 13 weeks and a reverse diet
(R)(C for 13 weeks, switched to B for 8 weeks). Aortae were excised, rings were
prepared, and two intact and two denuded rings were immersed in tissue baths containing
physiological salt solution (PSS) at 37OC, aerated with 95% 0 2 and 5% CO2 (pH 7.4).
Following equilibration and pre-conditioning under 1S g m preload, cumulative dose
response curves were generated with six doses of the a-1 adrenergic receptor agonist LPhenylephrine (L-Phe, 1O-' to 3 XI o-~M).Relaxation was induced in the rings with
).
denudation was assessed by the absence of
Acetylcholine (Ach, 3 x ~ o - ~ M Effective
relaxation to Ach and the maximal contraction and relaxation force (Fmax) was
determined. Intact arterial rings had a significantly lower Fmax than denuded rings
( 0 . 9 6 9 vs.
~ 3 . 0 7 6 ~(Pc0.05).
)
Mean Fmax of intact rings for C, B, and R groups

were 1.109, 0.873 and, 0.926gm (SEM=0.0463) respectively. A two-way ANOVA
demonstrated that B and R groups had a lower Fmax than C group when contracted with
L-Phe (pc0.05). There were no significant differences in Fmax means of denuded rings
among diet groups (p<0.05). Our results indicate for the first time that whole wild
blueberries function through the endothelium to influence the contractile machinery of
the rat aorta in response to an a-1adrenergic receptor agonist.
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CHAPTER 1
INTRODUCTION

Cardiovascular Disease (CVD) has plagued developed countries as the primary
cause of death for the past two decades accounting for nearly half of all deaths among the
United States adult population (1). Approximately 60 million people in the United States
have CVD with half of these individuals having no history of the disease (2, 3). CVD
occurs as a result of continuous damage to the dynamic and delicate vascular
endothelium that constitutes the inner layer of blood vessels (4, 5). The arterial integrity
is determined by the condition of the endothelium. Potentially, it is the compilation of
the various damaging factors that compromise the structural integrity of the artery (6- 10).
A dysfunctional vascular endothelium can be triggered by hypercholesterolemia,
hyperhomocysteinemia, hypertension or smoking (4).
Blueberries, containing polyphenols and other antioxidants, have the highest
antioxidant capacity of all fruits and vegetables. The possible roles of dietary flavonoids
and antioxidants are currently being examined in a variety of in vitro studies. The results
thus far have determined that polyphenols and antioxidants have beneficial effects on
maintaining the integrity of the vascular endothelium in vitro (10, 12, 13). In addition,
previous in vitro studies confirmed the beneficial effect of blueberry fractions on the
biomechanical properties of the artery (13). Pilot studies recently conducted in Dr.
Klimis-Zacas's laboratory determined that whole wild blueberries affect the mechanical
properties of the arteries (1 1). The pilot study results determined that blueberries
decrease the maximum force developed by the artery when challenged with the a- 1
antagonist, phenylephrine. However, whole wild blueberries do not affect the cell

membrane receptors, as indicated by the vessel reactivity. As a result, the mechanisms
by which blueberries affect the artery may involve the endothelium or smooth muscle
cells. The role of whole wild blueberries as a functional food, with respect to their site
and their mechanism of action on the endothelium, can only be evaluated and fully
understood through an in vivo study.
This project is a dietary study examining the effect of whole wild blueberries on
the biomechanical properties of the artery in vivo and its relationship to cardiovascular
disease. Sprague-Dawley rats will be fed diets with and without blueberries. The passive
and active properties of the vascular endothelium will be studied with the use of tissue
force analyzers. Animals intact and denuded arteries will be studied from all diet groups.
Denudation, removes the endothelial layer of cells from the artery. Thus, denudation,
mimics the damage that occurs to an artery with CVD. This data will provide the first
information on the role of whole bluebemes as a functional food with respect to arterial
integrity and CVD. This data will provide insight to blueberries' mechanism of action on
the endothelium with respect to CVD. Ultimately, the results of this research will also
indicate the possible implications whole wild blueberries may have on blood pressure
regulation.

The objectives of this thesis are:
1. To evaluate the role of whole wild bluebemes on the biomechanical properties (Fmax
and pDz) of the Sprague-Dawley rat artery.

2. To determine the site of the action of whole wild blueberries on the artery (smooth
muscle vs. endothelium)
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CHAPTER 2
LITERATURE REVIEW

2.1 Cardiovascular Disease
Even though the most recent medical advances and educational intervention
tactics have decreased the overall rate of cardiovascular disease (CVD) cases, CVD
continues to claim more lives in developed countries each year than any other disease (1).
More than 2,600 Americans die each day from CVD (2). Consequently, CVD causes one
death every thirty-three seconds (3). Approximately, one in five people have some form
of cardiovascular disease (4). CVD will cost the United States an estimated $35 1.8
billion in 2003 in health expenditures and lost productivity (5). The manifestations of
CVD include angina pectoris, chronic heart failure, coronary artery disease, myocardial
infraction, stroke, ischemic stroke and hypertension (6). CVD occurs as a result of
chronic endothelial inflammation, the trademark of atherosclerosis. Chronic inflammation
creates a dysfunctional endothelium and can be attributed to a variety of risk factors such
as: smoking, high concentrations of oxidized low-density lipoprotein (LDL), diabetes,
hypercholesterolemia, hyperhomocysteinemia, low levels of high-density lipoprotein
(HDL) and hypertension (7, 8). Physical inactivity, poor nutrition and being overweight
or obese are additional factors that can increase an individual's risk of CVD (6).
However, only 30% of CVD cases can be related to traditional risk factors (2-4).
Consequently, in order to decrease deaths related to CVD, a greater focus needs to be
dedicated to the prevention of CVD.

2.2 Endothelium and the Vascular Smooth Muscle Cell
The etiology of cardiovascular disease is based on the structural integrity and
health of the vessels of the cardiovascular system. The walls of an artery consist of the
intima, media, and adventitia (9). The intima, the innermost layer of the artery wall, is
contains a single layer of endothelial cells. The amorphous mucopolysaccharide ground
substance containing elastin, collagen, and vascular smooth muscle cells (VSM) is
referred to as the media layer. The VSM is composed of actin and myosin and undergoes
tonic contractions initiated by mechanical, electrical and chemical stimuli. The
adventitia, consisting of connective tissue, is the outermost layer surrounding the two
inner layers (10, 9).
The endothelium functions as the modulator of cardiovascular health by balancing
the vasoconstriction and vasodilatation of the artery. The vascular homeostasis achieved
by modulatory role of the endothelium occurs through mediators that act to affect the
musculature and vasculature of the artery (9). The vascular muscle activity of the aorta
affects its permeability to various vasoactive substances by directly regulating the
elasticity and distensibility of the aorta's vascular wall (1 1). The endothelium relays the
message of vasoactive substances by serving as a communication medium between the
blood and the VSMC. The vasoactive substances alter the vascular tone of the artery
through myogenic mechanisms, endothelial factors, local hormones or chemical
substances, and metabolic by-products. Consequently, signal transmission causes muscle
contraction or muscle relaxation and can occur through numerous pathways involving
nerve signals, blood-borne substances and locally generated substances (12).

Vasoactive substances functioning in the pathways act as vasoconstrictors or
vasodilators. Vasoconstrictors typically bind to receptors on the VSMC or endothelium
and can elicit a contraction. Angiotensin 11, vasopressin, endothelin- 1, norepinephrine
and thromboxane A2 are examples of vasoconstrictors (13, 14, 9). Vasodilators include
nitric oxide/endothelium derived relaxing factor (EDRF), endothelium-derived
hyperpolarizing factor, C-type natriuretic peptide and kinins. Acetylcholine causes
vasodilation through pathways involving NO, PGI2, and EDRF production (1 5, 16).
Vasorelaxation is stimulated by the release of the EDRFNO and can also be stimulated
by ATP, histamine, bradykinin, and other agents (10, 17). Vasodilators function to
protect the integrity of the artery by inhibiting VSMC growth, platelet aggregation,
platelet thrombosis, monocyte adhesion, inflammation and adhesion (7, 18). The
appropriate balance between vasoconstriction and vasodilation is maintained by a
functional endothelium and allows for a healthy cardiovascular system. The effect of
various vasoactive substances is illustrated in Table 2.1.

Table 2.1: The Effect of Vasoactive Substances on the Endothelium
Vasodilators
Nitric Oxide
Prostacyclin
Atrial Natriuretic Peptide
C-type Natriuretic Peptide
Kinins
Endothelium-derived
Hyperpolarizing factor

Vasoconstrictors
Angiotensin I1
Endothelin
Vasopressin (Anti-diuretic hormone)
Cytokines
Thrombin
Oxygen Free Radicals
Shearing Forces

Adapted from Klabunde et a1 and Hsueh et a1 (7, 12)
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The autonomic nervous system, composed of the sympathetic and
parasympathetic systems, can regulate the flow of blood based on the degree of vascular
tone present in the artery. The a-1 and a-2-adrenergic receptors, located in the aorta's
VSMC, bind with agonists to cause vasoconstriction (10, 19). Vasoconstriction occurs via
the sympathetic nervous system due to the activation of noradrenaline or norepinephrine
and subsequent binding to a-adrenoreceptors (9). An agonist is a substance that interacts
with receptor molecules to produce an effect identical to the endogenous signaling
molecule. For instance, phenylephrine is an alpha-1 adrenergic agonists for
norepinephrine that can elicit a contraction (20,21). Whereas an antagonist, is a
substance that binds to a receptor, competes with the hormonal signal and prevents the
response of the hormonal signaling molecule (9).
Also located in the blood vessels are P-adrenergic receptors that inhibit
contraction and cause vasorelaxation in the VSMC (9). Acetylcholine, released into
circulation by the parasympahthetic nervous system, causes vasoconstriction under
resting vascular tone and vasodilatation under raised vascular tone (20). The effect of
acetylcholine is termed biphasic because its effect is based on the level of vascular tone.
Acetylcholine affects pathways of vasoactive substances including factors such as NO,
PG12 and EDRF (16, 22). The degree of relaxation that occurs in the presence of
agonists binding the P-adrenergic receptors is based upon the degree of contraction
present in the artery. In other words, for relaxation to occur a certain level of contraction
must be present in the artery.

In addition, P-adrenergic receptors also experience

desensitization that causes their effects to diminish with increased exposure to agonists

(1 0, 17, 21). Consequently, vascular tone of the artery determines the effect that the
parasympahthetic nervous system has on blood flow.
Alpha and P receptors can be present in the same vessel and also share the same
neurotransmitter, norepinephrine (9). The a and P effect of norepinephrine is based on
receptor affinity. Typically the a receptor has the highest affinity for norepinephrine and
causes a contraction. Beta-receptors generally have a higher affinity for epinephrine than
norepinephrine and elicit a relaxation (1 7). There are a variety of biologically active
substances that bind specifically to various cell receptors of the aorta initiating a complex
cascade of events (23) capable of causing a relaxation or contraction. Ultimately, the
contraction or relaxation induced by the binding of a neurotransmitter or agonists has on
the artery's vasculature depends on several known and even unknown factors. The effect
is dependent upon the vascular tone present in the artery, the vasoactive substance
binding the receptor and the effect the cascade of events have on the calcium
concentration in the VSMC (21).
Ultimately, neurotransmitters and vasoactive substances affect the concentration
of intracellular calcium via signal transduction mechanisms and determine the VSMC
contraction. Increases in intracellular calcium cause calcium to bind to calmodulin, a
special calcium binding protein (9). The binding of calcium to calmodulin forms a
calcium-calmodulin complex and causes the activation of the enzyme myosin light chain
kinase (MLCK). With ATP, MLCK causes the phosphorylation of myosin light chain
(MLC), resulting in the formation of a cross-bridge between myosin and actin and a VSM
contraction (22). Calcium concentrations are regulated by the phosphatidyinositol

pathway, G-protein-coupled pathway, and nitric oxide-cGMP pathway (24). The
complexity of the pathways influencing VSMC contraction is illustrated in Figure 2.1.
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Figure 2.1: Signal Transduction Pathways Affecting Vascular Tone in the VSMC
,

NE
AII
ET-1

NE: norepinephrine, AII: angiotensin 11, ET- 1 : endothelin-I, PL-C: phospholipase
C, PIP2: phosphatidylinositol, IP3: inositol triphosphate, SR: sarcoplasmic reticulum,
DAG: diacylglycerol, PK-C: protein kinase C, P2: P receptor, Epi: epinephrine, Gs: G
protein pathway stimulated, Gi: G protein pathway inhibited, AC: adenyl cyclase, NO:
nitric oxide, GC: guanyl cyclase, MLCK: myosin like chain kinase, Ca: calcium, GTP:
guanyl triphosphate, GDP: guanyl diphosphate, CAMP: cyclic adenosine monophosphate,
ATP: adenosine triphosphate. Klabunde et al. 2002 (12)

Nitric Oxide (NO), the most important vasodilating substance, previously was
referred to as endothelium derived relaxing factor (EDRF) (9). The role of nitric oxide is
central to the modulatory function of the endothelium. The vascular protective functions
of NO include; vasodilation, inhibiting sympathetic vasoconstriction, inhibiting platelet
and leukocyte adhesion to the endothelium, inhibiting VSM proliferation, preventing
thrombosis and scavenging superoxide aninon to prevent inflammation (1 3, 16, 25).
Nitric oxide is produced in the endothelial cell from the oxidation of L-arginine to Lcitrulline by nitric oxide synthase (NOS). Nitric oxide synthesis is presented in figure
2.2.

I

Figure 2.2: Nitric Oxide Pathway

Endothetial
Cell

Smooth

Muscle Cell

Klabunde et al. 2002 (12)

Nitric oxide synthase has three isoforms, NOS-1, NOS-2, and NOS-3. Neural
NOS (nNOS) or NOS-I and endothelial NOS (eNOS) or NOS-3 are present during
baseline physiological conditions (N20). Inducible NOS (iNOS) or NOS-2 is expressed
during inflammatory physiological states (26, 27). Nitric oxide, produced in the
endothelial cell, activates guanyl cyclase in the VSM to increase concentration of cyclicGMP. The increased cGMP is capable of activating cGMP-dependent protein kinase.
Activation of the protein kinase stimulates the following pathway; inhibition of calcium
entry into the VSM, decreased calcium-calmodulin MLCK binding, decreased
phosphorylation of myosin light chains, reduced contractile forces and vasodilation. The
mechanism of NO- induced relaxation is portrayed in Figure 2.2 (9). Acetylcholine,
bradykinin, substance-P, insulin, and histamine stimulate the production of NO by
increasing the calcium concentration. Also, shear force created by blood flow can result
in calcium release and cause eNOS to increase the production of NO. Inducible NOS is
capable of increasing NO production in the presence of cytokines and bacterial
endotoxins. Each of these mechanisms that increase NO production serve an important
function in the cardiovascular system. The effect of NO is based on its production and
bioavailability. The bioavailability can depend upon the presence of reactive oxygen
species, intracellular availability of L-arginine, altered NOS activity and impaired
receptor mediated release of NO (6, 12, 14). Along with the protective and regulatory
role of NO, the cardiovascular system also possesses a series of defense mechanisms. The
antioxidant defense mechanisms that function to prevent damage are composed of
antioxidant enzymes and include; superoxide dismutase (SOD), catalase, gluthione

peroxidase and glutathione reductase (9). In addition, glutathione, a-tocopherol and
ascorbic acid are free-radical scavengers that help to maintain arterial integrity (6,28).

2.3 Cardiovascular Disease and Endothelial Dysfunction
The health of the cardiovascular system is determined by the condition of the
endothelial cells. Various circulating factors have the potential to impair the modulatory
role of the endothelial cells and cause vascular injury and disease. Consequently,
cardiovascular disease is characterized by a dysfunctional endothelium. As the modulator
of cardiovascular health, the endothelium controls platelet aggregation, fibrinolysis,
vascular tone, growth, immune responses, smooth muscle cell proliferation and thrombus
formation (9). Each of these components has the potential to cause inflammation and
create a dysfunctional endothelium (13, 8). The endothelium functions to maintain
vascular homeostasis and tone through paracrine mediators by regulating the
vasodilatation and vasoconstriction of the artery. Paracrine mediators are vasoactive
substances that only affect the target cells in close proximity to the cell releasing the
mediators. A dysfunctional endothelium causes a disruption in the delicate balance of
paracrine mediators regulating the vasoconstriction and vasodilatation (8). A disruption
in the balance of paracrine mediators regulating the vascular endothelium, causes a loss
of normal anti-platelet activity, vasodilator or anti-thrombotic activity, increases the
potential the likelihood of vasospasm, thrombiosis or further inflammatory damage (29).
Consequently, the role of the endothelium is to balance the dilation and contraction of the
artery in order to maintain the arterial integrity.

Inflammation, a multi-factorial process that causes a dysfunctional endothelium,
is the main characteristic associated with the development and progression of
atherosclerosis (8). Atherosclerosis is a form of CVD and is characterized by chronic
inflammation. Cellular and molecular responses to the chronic inflammation cause the
development and progression of arterial lesions. Initially, inflammatory stimuli cause the
up-regulation of surface and soluble cell adhesion molecules and the release of cytokines
(13). During inflammation platelets release pro-inflammatory mediators including
thromboxane A2 and serotonin (30). Early atherosclerotic events include the adhesion of
platelets and monocytes to the endothelium. This process is referred to as the activation
of the endothelium and is the initial event in the atherosclerotic process. Injury to the
arterial wall from chronic inflammation results in the disruption of the physiological
protective regulatory balance of the endothelium, another factor in the development of
atherosclerosis. Growth factors are then released from platelets, endothelial cells,
macrophages, and VSMC that further enhance the inflammatory process (3 1). Continued
inflammation results in the enhanced release of hydrolytic enzymes, cytokines,
chemokines, and growth factors from the activated endothelium. The release of these
factors attracts circulating monocytes that then bind to adhesion molecules and migrate
into the subendothelial space. Lipid-laden foam cells or fatty streaks develop from
monocyte-derived macrophages that scavenge oxidized LDL and migrate into the
subendothelial space. As the process is augmented, VSMCs migrate and extracellular
debris, lipids, and cholesterol crystals are deposited around the lesion. The deposition of
calcium is followed by necrosis of the foam and endothelial cells. The fibrous plaque

formed, is composed of the core lipid and necrotic tissue. Hemorrhage and thrombosis
characterize the final stages of atherosclerosis (6, 8, 31).
Oxidative stress contributes to the atherosclerotic process and occurs when there
is an imbalance between in vivo antioxidant defense mechanisms and the production and
exposure of cells to reactive oxygen species (ROS) and reactive nitrogen species (RNS).
Superoxide, hydroxyl, peroxyl, oxides of nitrogen, and peroxynitrite are all examples of
reactive oxygen and nitrogen species that can cause oxidative stress (32). These free
radical species can oxidize LDL particles (33). Thus, the atherosclerosis process can also
be initiated and intensified by the oxidized LDL trapped within the lesion. The oxidative
modification hypothesis and the research supporting this hypothesis provide the evidence
that links CVD to the inflammation caused by oxidized LDL (34). A high concentration
of plasma LDL particles results in the increase of both circulating monocytes adhering to
the arterial wall and to a higher concentration of LDL particles entering the intima.
Consequently, there is an increased chance of the LDL particle to become oxidized. In
vitro studies discussed by Steinberg et al., state that foam cell formation occurs from

macrophages/monocytes and smooth muscle cells that bind modified or ox-LDL (35). In
addition, Tapiero et al. discussed in vitro studies that determined the simple incubation of
LDL overnight with endothelial cells or smooth muscle cells created a foam cell,
providing yet another mechanism by which LDL could hnction in foam cell formation
(9, 35). Also, Noguchi et al. recently completed research indicating that ox-LDL not only

damages the endothelium physically, but ox-LDL also induces a variety of proatherosclerotic genes (28). It is widely accepted that oxidized LDL play a critical role in
the atherosclerotic process by exerting several harmful effects on the endothelium (36).

Oxidized LDLs' cytotoxic effects include, increasing the production of growth factors,
inhibiting the release of NO and increasing leukocyte adhesion to endothelial cells (36).

In humans, both observational and experimental studies have demonstrated an
association between inflammation and endothelial dysfunction (8). Researchers have
concluded that there are morphological and functional changes in the endothelial cells
located in areas prone to atherosclerosis (37). Endothelial cells that undergo these
changes have impaired dilation and have a diminished protective role against the
atherosclerostic process (37). Goode et al. concluded through an in vitro study that
human hypercholesterolemic peripheral arteries exhibit vascular abnormalities because of
impaired endothelial function (38). Ishibashi et al. observed vascular abnormalities
manifested by an impaired endothelium that affected forearm blood flow among patients
with congestive heart failure (39). Numerous other studies have established two primary
associations regarding the impaired functioning of the cardiovascular system. First,
studies have confirmed an association between low-grade inflammation and
atherogenesis (29). The second association is a relationship between acute systemic
inflammation and increased risk for a cardiovascular event (29). Hingorani et al.
determined a relationship in humans between endothelial dysfunction and risk of CVD, in
the presence of a Salmonella typhi vaccine. The vaccine created a mild inflammatory
event and the researchers observed impaired endothelium dependent vasodilation among
the human subjects (29). These studies are only a few of the numerous studies that
document the association between inflammation, endothelial dysfunction and risk of
cardiovascular disease.

Along with impairment of endothelial function, hyperesponsiveness of the
vascular smooth muscle can also lead to endothelial damage, vascular injury and disease.
Hyperresponsiveness of the VSMC can potentially cause enhanced vasoconstriction.
Atherosclerosis and hypertension enhance the contractile effects of the artery and tend to
predispose a patient to myocardial ischemia (38, 39). In addition atherosclerosis and
hypertension are risk factors for myocardial infraction. However, atherosclerosis and
hypertension reduce endothelium dependent responses to acetylcholine, bradykinin,
thrombin and platelet derived products causing enhanced contractile effects. Goode et al.
determined that hypertension and atherosclerosis in animal and human subjects enhanced
the contractile effects of serotonin (38). Hyperresponsiveness of the VSMC or
impairment of the endothelium are capable of affecting the integrity of the artery and the
endothelium derived relaxation. Denudation, removal of the intima layer of the
endothelium, mimics the arterial damage that occurs during atherosclerosis and impairs
the release of EDRF/NO.
EDRF/NO is produced by the endothelial cell and relaxes VSMC by activating
guanylate cyclase to form cyclic GMP by protein phosphorylation. NO activity is
responsible for vasodilation, lowering of blood pressure, inhibition of platelet
aggregation, inhibition of platelet and leukocyte adhesion to the vascular endothelium,
inhibition of VSMC proliferation and scavenging superoxide anions (12). Thus NO can
function as a superoxide scavenger by reacting with superoxide anion to form
biologically inactive nitrate. On the other hand, NO and superoxide can also form
peroxynitirite radical which can form a hydroxyl radical (33). Peroxynitrite is capable of
causing oxidative damage associated with the pathogenesis of inflammatory disease (40).

Thus, the biological activity of NO to function as an oxidant or oxidant scavenger is
based on the intracellular formation of superoxide anion.
The role of NO is central in the regulation and the pathogenesis of cardiovascular
diseases (41). The dysfunctional endothelium of atherosclerotic arteries impairs the
synthesis, release and functions of EDRF/NO (9). Many diseases and conditions have
been associated with decreasing the production of nitric oxide and impairing
endothelium-dependent vasorelaxation. Hypertension, atherosclerosis, diabetes, obesity,
dyslipidemias, heart failure, cigarette smoking, aging and vascular injury are diseases or
conditions known to damage the endothelium and reduce the expression of eNOS (1 2,
42). Normal release of NO through the eNOS reaction is responsible for physiologic
vasodilation. However, studies have determined that during septic shock, NO production
through iNOS is possibly responsible for regulation of blood pressure and endogenous
antioxidants (4 1). Numerous experiments have indicated that EDRF/NO is decreased in
the beginning of the atherosclerotic process and decreased NO production has been
observed to be a mechanism responsible for the endothelial dysfunction (9). Impairment
of NO production can cause thrombosis from platelet aggregation and adhesion,
inflammation from tissue damage by ROS, vascular stenosis or vasoconstriction (12). A
correlation was shown by Cleland et al. between basal endothelial NO synthesis and lowgrade inflammation (8). Thrombosis, myocardial infraction and reperfusion injury are
cardiovascular complications that have been observed to have an impaired production
and effect of NO (43). Nitric oxide production is also affected by pathologies damaging
the endothelium, hypoxia, or trauma (44). Consequently, disruption in the NO function,

has been widely implicated in creating a dysfunctional endothelium and being a crucial
factor in the progress of cardiovascular disease (43).

2.4 Blueberries
2.4.1 Composition of Blueberries

Lowbush blueberries, Vaccinium angustifolium, also referred to as whole wild
bluebemes, are commonly referred to as antioxidant powerhouses. The components of
low bush blueberries are water, carbohydrates, eleven minerals and five vitamins (45).
Bushway et al. determined that niacin, riboflavin, thiamin, vitamin C and vitamin A are
the five vitamins found in blueberries (45). The minerals are calcium, potassium,
magnesium, phosphorus, aluminum, boron, copper, iron, manganese, sodium, and zinc
(45). Despite the antioxidant vitamin content of bluebemes, Prior et al. concluded that
the polyphenolic compounds of blueberries contribute substantially to their antioxidant
capacity (46). Polyphenolic compounds consist of phenolic acids, their esters and
flavonoids. Blueberries have been determined to have the highest oxygen radical
absorbance capacity (ORAC) of all h i t s and vegetables (47,48). Prior et al. confirmed
a direct correlation between the total ORAC and the total polyphenolic content of various
blueberries (49). Kalt et al. reported that lowbush blueberries, Vaccinium angustifolium,
have higher concentrations of anthocyanins, total phenolics and ORAC than the species
of high bush "cultivated" blueberries (48).
Polyphenols function as reducing agents and can function to regenerate other
antioxidants, such as vitamin E. The antioxidant capacity of polyphenols is provided by
phenolic group's ability to function as hydrogen donors. The polyphenolics posses an

aromatic ring bearing one or more hydroxyl substituents. Polyphenols also posses metalchelating properties that possibly allow them to decrease iron and copper induced
oxidations (50).
Among the flavonoids are the flavans, flavonols, proanthocyanidins, and
anthocyanins. Kalt and McDonald determined that chlorogenic acid is the major
phenolic acid in the low bush blueberry. Other major organic acids include citric (36%),
malic (3 1%) and quinic (20%) (5 1). The major flavonols found in blueberries are
kaempferol and quercetin (52). Proanthocyanins, higher molecular weight component of
the blueberry, are a type of tannin found in bluebemes that have been shown to inhibit
the initiation stage of chemically induced carcinogenesis (53). Five major anthocyanins
have been reported in the lowbush blueberry. The five anthocyanins, delphinidin,
malvidin, petunidin, cyanidin and peonidin, are shown in figure 2.3 and table 2.2 (54).
The anthocyanins in the lowbush blueberry are found as their 3-glucosides, 3galactosides and 3-arabinosides. According to Prior et al., the total anthocyanin content
of lowbush blueberries is 95.4

* 2.6 mg/l OOg of bluebemes (49).

Based on a 1976 study

conducted by Kuhnau et al., the estimated average U.S. American anthocyanin intake was
180 g in the winter and 21 5 g in the summer (55). Tsuda et al. explained the variation in
favonoid stating that human consumption of flavonoid ranges from 25 mg/day to
lmg/day (56). According to Marchand et al., flavonoid intake varies among different
countries from 3 mg in Finland to 68 mg in Japan (56).

Figure 2.3: The Flavylium Cation. R1 and R2 are H, OH, or 0CH3; R3 is a glycosyl or

H; and R4 is OH or a glycosyl. Excerpted from Kong et al. (57)

Table 2.2: Five Major Anthocyanidins Reported in the Vaccinium angustifolium
Name

Abbreviation 3

Cyanidin

Cy

5

6

7

3'

4'

5'

Color

OH

OH

H

OH

OH

OH

H

Orange-red

Delphinidin Dp

OH

OH

H

OH

OH

OH

OH

Bluish-red

Malvidin

My

OH

OH

H

OH

OMe OH

OMe Bluish-red

Peonidin

Pn

OH

OH

H

OH

OMe OH

H

Orange-red

Petunidin

Pt

OH

OH

H

OH

OMe OH

OH

Bluish-red

OH: hydroxyl, H: hydrogen, OMe: methyl
Excerpted from Kong et al. (57)

Although in the past, information on bioavailability has been referred as being
scarce, researchers have recently made considerable contributions to the areas of
flavonoid absorption, metabolism and excretion in humans and rats. Numerous
researchers have observed the absorption of flavonoids from poly-phenolic rich foods
across the gut barrier by obtaining measurements of the plasma antioxidant capacity
before and after consumption (46, 57). Most recently, Kay et al. observed the ORAC and
total antioxidant status (TAS) of eight men's plasma who had consumed 100 g of fieezedried blueberries with a high fat meal in a single blind cross-over study. Kay et al.
determined that the diet-induced ex vivo increase in serum antioxidant status, was
directly associated with the observed in vitro antioxidant content of blueberries (58). The
antioxidant activity observed is influenced by the absorption of the flavonoid. According
to Heim et al. the absorption is affected by the mode of administration, antecedent diet,
dosage amount, gender differences, and colonic microflora (59). For instance, iron and
protein may bind flavonoid hydroxyl groups and hinder their absorption (60).
The structure of the flavonoid affects the absorption mechanism and the
biological benefits of the metabolized flavonoid. Flavonoids naturally occurring in plants
exist mostly as glycosylates rather than as aglycones, the form with the sugar moiety
removed. However, until recently most research on flavonoid absorption was conducted
on aglycones. The glycosylation of the sugar affects the absorption, metabolism and
biological benefits of the flavonoid (52). Flavonoids containing sugars can be
hydrolyzed at the brush border allowing the aglycones to diffuse across the cell
membrane. Flavonoids with sugar moieties may also cross the enterocyte border via the
sodium-dependent glucose transporter. Regardless of absorption, cleavage of the

glycosides by the cytosolic P-glycosidase can occur (52). Flavonoids are conjugated in
the intestinal cells and bound to albumin for transport to the liver (30). In the liver, the
flavonoid can be further conjugated with methylation or sulfation. The extent of
conjugation is associated with the biological capacity of the flavonoid. For instance, in a
review paper Nijveldt et al. hypothesized that the extent of conjugation is directly related
to decreased toxicity, antioxidant activity and enzyme inhibiting capacity of the flavonoid
(30). Mananch et al. demonstrated that continuously high intakes of the flavonoid
quercetin in rats decreased absorption but increased the formation of the conjugated form,
which has more antioxidant activity than the aglycone form (61). Paganga and RiceEvans et al. confirmed that dietary flavonoids were absorbed as glycosides by identifying
the presence of anthocyanins, rutin, and quercetin glycosides in human plasma through an
in vivo study (62). The investigation confirmed that a polyphenolic plasma concentration

required to attain 50% of maximal relaxation, 0.5-1.6 pmol/L, was detected in human
subjects. Miyazawa et al. also confirmed the intestinal absorption, in humans, of orally
administered anthocyanin extracts, cyanidin glucosides, and the subsequent increase in
plasma concentration and antioxidant capacity (62). However, Wu et al. was unable to
detect anthocyanins in the plasma of six women who consumed a 189 g of low bush
blueberries as a meal. Wu et al. concluded that the anthocyanins were poorly absorbed
and that only 0.004% of the l89g consumed was detected in the urine 6 h later (63).
Tsuda et al. investigated the in vivo mechanism for the absorption and metabolism of 3-0P-D-glucoside (C3G) in rats. After the oral administration of 0.9rnrnolkg 3-0-P-Dglucoside body weight the following mechanism was purposed (56). First, C3G is
hydrolyzed by P-glucosidase in the intestines and the aglycones of cyanidin (Cy), C3G,

is produced and degraded to protocatechuic acid (PC). Consequently, the free form C3G,
observed in the previously discussed studies on rats and humans, may improve the
antioxidant activity of this flavonoid (56). Numerous studies have confirmed the
absorption of anthocyanin intact glycoside forms by detection in plasma and urine.
Thus, more research is needed to understand the absorption, metabolism, biological
benefiting mechanisms and excretion of dietary flavonoids in both humans and rats.
The role of blueberries in disease prevention and treatment can be attributed to
their ORAC value, among other beneficial components (47,48). The metabolites of
polyphenolic compounds produced during the digestion provide the blueberries with the
high ORAC value. The high ORAC value allows the blueberries to protect the body from
oxidative stress. According to Scalbert et al., the health benefits associated with
blueberry consumption may correlate with the polyphenolic concentration and functions
(46). Currently, research has indicated that blueberries have possible health benefit's in
protecting against chronic diseases and include, preventing glaucoma, fibrocystic disease
of the breast in humans, cancer, cerebrovascular conditions, diabetes, atherosclerosis, and
cardiovascular disease (30). The anthocyanins, delphinidin and cyanidin, have also been
identified as having other therapeutic effects acting as radiation-protective agents,
vasotonic agents, chemoprotective agents, hepatoprotective agents and anti-inflammatory
agents (47). Anthocyanins have also been postulated to function in the treatment of
microcirculation disease and prevention of cholesterol-induced atherosclerosis in the
rabbit (47).
The vast majority of the research conducted thus far has been on the polyphenolic
extracts of blueberries rather than on the whole wild blueberry itself. The research

conducted on the extracts has been mostly in vitro (61, 68). Consequently, the role of
whole wild blueberries in preventing various chronic diseases is accepted because of the
high ORAC value of the blueberry's polyphenolic components. Blueberries are potential
candidates in disease prevention and treatment, however, in vivo research is lacking and
further studies are critical to understand their benefits on human health (48).

2.4.2 Flavonoids
Flavonoids have been documented to have beneficial effects as antioxidants,
antiviral, anticancer, anti-inflammatory, anti-allergic and anti-atherogenesis components
through in vitro experiments (30,64). According to Schramm and German flavonoids
may function to protect vascular health by the following mechanisms: free radical
termination, protease inhibition, inhibition of the Maillard reactions, growth suppression
of bacteria and prevention of leukocyte adhesion (65). Flavonoids have been proven to
inhibit the atherosclerotic process in many animal studies (66). Aviram et al. examined
the effect of pomegranate juice (PJ) on the atherosclerotic process in human subjects and
atherosclerotic apolipoprotein e-deficient mice. PJ contains the following anthocyanins:
cyanidin-3-glucoside, cyanidin-3, 5-diglucoside and delphindin-3-glucoside. Aviram
concluded that PJ decreased LDL susceptibility to aggregation in humans and in mice PJ
reduced oxidation of LDL by 90%, reduced uptake of oxidized LDL by 20%, reduced the
size of atherosclerotic lesions by 44% and the formation of foam cells. This study
concluded that in atherosclerotic mice and humans PJ antioxidative properties provide
antiatherogenic effects (67). Consequently, flavonoids have potential effects in
improving vascular health by reducing platelet aggregation, improving capillary

permeability, reducing leukocyte adhesion, oxidative stress, and improving vasodilation
of the arteries (68).
Bravo et al. summarized the possible protective mechanisms of flavonoids to
reduce free radical formation, protect alpha tocopherol in LDL from oxidation, increase
regeneration of oxidized alpha tocopherol and chelating metal ions (50, 59). Flavonoids
are potent antioxidants that function as oxidizing species scavengers, neutralizing
superoxide anion, hydroxyl radicals, peroxy radicals or as quenchers of a reactive oxygen
species (59,69, 70). Flavonoids react with free radicals to terminate the propagating
chain reaction (71). The in vitro antioxidant capacity of flavonoids is directly related to
the degree of hydroxylation. Another antioxidant mechanism determined by Arora et al.
is the ability of flavonoids is to decrease membrane fluidity and stabilize membranes
(72).
Flavonoids have been observed to function in twenty- four enzyme systems.
VanHoorn et al. investigated the effect of flavonoids on xanthine oxidase, an enzyme that
increases during periods of oxidative stress (64). During the re-oxidation of xanthine
oxidase, both harmful superoxide radicals and hydrogen radicals are produced. VanHoorn
et al. determined that flavonoids with hydroxyl groups located at the 5 and 7 position on
the flavone backbone possessed the strongest xanthine oxidase inhibitory effect (64).
Other effects flavonoids have on the enzyme systems include pathways involving; cell
division, platelet aggregation, detoxification, inflammatory and immune responses (73,
74). The inhibitory effects of flavonoids are associated with enzymes involved in cell
activation including, protein kinase C, protein tyrosine kinase and phospholipase A2 (75).
Smith et al. conducted an assay used to detect cancer preventive action and determined

that flavonoids from wild bluebemes inhibit the initiation stage of chemically induced
carcinogenesis (53). There is also substantial experimental evidence regarding the action
of flavonoids in various cancer-related biological pathways. The cancer-related pathways
that flavonoids affect include; carcinogen bioactivation, cell signaling, cell cycle
regulation, angiogenesis, oxidative stress and inflammation (74). Studies on a variety of
flavonoid sources have determined that the flavonoid and antioxidant content in red wine,
black tea, green tea, fruit juices and chocolate can function to inhibit LDL oxidation (66,
67, 68, 76, 77, 78 79).
The structure of flavonoids is directly associated with the ability of the flavonoid
to function as an antioxidant or prooxidant. Galati et al. determined that polyphenolics
containing a polyphenolic ring are more prooxidant than polyphenolics containing a
catechol ring (80). According to Skibola et al. the result of excessive flavonoid intake
causes the flavonoid to function as a mutagen, pro-oxidant and inhibitor of key enzymes
(8 1). Further research is needed to elucidate the potentially toxic effects associated with
excessive flavonoid intake and the intake levels that cause these effects. The antioxidant
functions of flavonoids pertain to their ability to scavenge radicals, scavenge the high
concentrations of nitric oxide created by macrophages via nitric-oxide synthase, and
inhibit xanthine oxidase activity causing less oxidative damage (69).
Flavonoids have been implicated to have a preventive role in a number of
inflammatory and disease processes including; asthma, cancer, cardiovascular disease,
cataracts, diabetes, gastrointestinal inflammatory diseases, liver diseases, macular
degeneration and periodontal disease (82). Figure 2.1 presents the hypothetical effects of
flavonoids on disease mechanisms.
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Figure 2.4: Hypothetical Mechanisms of the Role of Flavonoids on Diseases
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2.4.3 Anthocyanins
Anthocyanins, the most abundant flavonoid found in blueberries, are located
within the outer layer of the blueberry and are responsible for the blue pigmentation of
the blueberry. The Greek origin of the word anthocyanin is anthos, which means flower,
and kyanos, which means blue. Anthocyanins, a phenolic phytochemical, are found
throughout the plant kingdom and in the diet as crops, beans, fruits, and vegetables and in
red wine (30,40). Anthocyanins found in the lowbush blueberry, as presented in Figure
2.3 and table 2.2, include delphinidin, malvidin, petunidin, cyanidin, and peonidin (54).
Although blueberries contain ascorbic acid, it is their anthocyanin content that is
attributed to providing their high antioxidant capacity (53).
Tsuda et al. investigated the anti-oxidative, radical scavenging and lipid
peroxidation inhibitory effects of three anthocyanins extracted from Phaseolus vulgaris.
The three anthocyanins, pelargonidin 3-O-P-D-glucoside (P3G), cyanidin 3-0-P-Dglucoside (C3G), and delphinidin 3-O-P-D-glucoside (D3G) are three of the five
anthocyanins found in lowbush blueberries. In addition, the aglycones, pelargonidin
chloride (pel), cyanidin chloride (Cy) and delphindin chloride (Del) antioxidative activity
were evaluated. The anti-oxidative activity was evaluated as reduced malondialdehyde
by UVB radiation in a liposomal system. Each extract demonstrated strong antioxidative
activity, but the radical scavenging and antioxidative activity were associated with each
pigments structure (83). Other studies by Tsuda et al. documented that anthocyanins
have antioxidant ability under physiological conditions during both in vivo and in vitro
experiments (40). Tusda et al. concluded that the anthocyanin, cyanidin, is readily
absorbed and metabolized in rats and was found to create a high serum antioxidant

capacity (40). Antioxidant activity of anthocyanins was determined based on effects on
LDL oxidation and the lecithin liposome system in vitro by Gracia et al. (73). Gracia et
al. determined that the ability of the anthocyanin extracts to inhibit oxidation increased as
follows; pelargonidin < cyaniding < delphinidin < malvidin. The researchers determined
that the antioxidant capacity of anthocyanins is affected by the metabolic system, the
substrate and conditions used to catalyze the oxidation (73). Gabrielska et al. revealed
that anthocyanin extracts of honeysuckle and chokeberry function reduced LDL oxidation

in vivo (84). Frank et al. recently documented the effect of dietary anthocyanins ability
to spare vitamin E in healthy rats in vivo (85). Other studies have determined the
antioxidative activity of anthocyanins to be concentration and dose dependent (40, 84).
In 1976, Kuhnau et al. documented for the first time that anthocyanins can
function in metal chelation (55). Further research by numerous investigators, has
concluded that anthocyanins function as inhibitors of lipid peroxidation, as free radical
scavengers or in biological systems through metal chelation or protein binding (73, 83).
Sarma et al. identified that anthocyanins chelate metal ions to prevent the oxidation of
ascorbic acid by forming an ascorbic metal anthocyanin complex (86).
Various studies have confirmed the biological effect of anthocyanin extracts.
Joseph et al. discovered that anthocyanin extracts are important in neurological
functioning. They determined in numerous studies that anthocyanin extracts can decrease
the occurrence of the parameters commonly associated with several age-related neural
dysfunction conditions and cognitive decline (87). Obi et al. concluded that anthocyanin
extracts from N rosasinensis administered to rats prevented carbon-tetrachloride induced
liver damage (88). Anthocyanins cyanidin (Cy) and delphinidin (Del) have been found

to inhibit tyrosine kinase activity of epidermal growth-factor receptor and inhibit growth
of human tumor cells in vitro by Meiers et al. (89). Other research has confirmed the
effect of anthocyanins on anti-inflammatory activity, anti-convulsant activity, antioxidant
activity, and anti-carcinogenic activity (73). Studies have documented the antioxidant
capacity of anthocyanins to contribute to the following biological effects; decreased
capillary permeability and fragility, reduced platelet aggregation and strengthening the
collagen matrix of connective tissue (68).

2.5 Cardiovascular Disease and Blueberry Components
2.5.1 Dietary Intake and Cardiovascular Disease
Multiple mechanisms are capable of functioning to activate the vascular wall and
thus compromise the arterial integrity of the vascular system. Epidemiological,
observational, and experimental studies have produced a substantial amount of evidence
linking the consumption of antioxidant containing fruits and vegetables to reduced risk of
cardiovascular disease or improved cardiovascular health (32). According to Morton et
al. the antioxidant content, including b-carotene, vitamin C, vitamin E and the
polyphenolics, are responsible for reducing the risks of CVD and cancer (32). The Seven
Countries Study, conducted by Hertog et al., evaluated the association between flavonoid
intake and CHD among 16 cohorts, from seven different countries, in men between 65-84
years of age from 1960 to 1985 (90). Average flavonoid intake and mortality rates were
inversely related with 90% of the variance explained by saturated fat intake and smoking.
Hertog et al. investigated flavonoid intake and mortality associated with coronary heart
disease (CHD) in one of the six cohorts from the Seven Countries Study, the Netherlands

cohort, in an epidemiological survey called "The Zutphen Elderly Study" (91). The
sources of flavonoids were tea, onions, and apples with the daily average flavonoid intake
being 25.9 mg. The findings of the Zutphen Elderly Study determined inverse
relationships between flavonoid intake and mortality from CHD (p=0.015) and incidence
of myocardial infarction (p=0.08). In addition, the result of the Zutphen Elderly Study,
revealed a dose dependent association between flavonoid intake and CHD mortality (91).
Knekt et al. determined a weak inverse relationship between flavonoid intake and CHD
among 5 130 Finnish men and women over a 20-year period (92). On the other hand,
Rimm et al. in the U.S. Health Professionals Follow-up Study identified a very weak
inverse relationship between flavonoid intake and total CHD (93). However, this study
that found a poor correlation between CHD and flavonoid intake only evaluated the
presence of CHD, not mortality rates from CHD. In conclusion, although
epidemiological and observational studies are not conclusive they indicate the potential
benefits of flavonoid consumption with respect to CVD (V). More recently,
epidemiological evidence regarding the intake of red wine, principally composed of
polyphenolic compounds, has generated the concept of the "French Paradox" (94). The
red wine consumption among the French population may be partially responsible for the
reduced incidence of CHD among the French population. Hayek et al. determined that
mice deficient in apolipoprotein E, which spontaneously develop atherosclerosis, had
significantly reduced lesion development when fed red wine or quercetin (95).
Yamakoshi et al. determined that proanthocyanidin extract from grape seeds inhibited
atherosclerosis lesion development in cholesterol-fed rabbits (96).

Observational studies have identified flavonoids as having a protective effect
against CVD. Later studies discussed the in vitro role of flavonoids and have revealed
the protective antioxidant activity of phenolic compounds (32). However, researchers
postulate that some cardiovascular benefit of polyphenolic consumption may be
independent of polyphenolic antioxidant capacity and attributed to the endothelium-NO
dependent relaxation through the NO-cGMP pathway. Regardless, current research
efforts are being directed towards understanding the mechanisms and identifying both the
individual dietary plant compounds and whole functional foods that may protect against
CVD.

2.5.2 Adhesion and Aggregation
Flavonoids affect platelets, monocytes and VSMCs through a variety of
mechanisms that directly influence the cardiovascular system (30). According to a
review by Harborne et al., flavonoids have been demonstrated to affect cardiovascular
health by inhibiting platelet adhesion to the endothelial wall, aggregation, and secretion
(30). Up-regulation of inflammatory mediators, platelet aggregation and endothelial
adhesion are critical steps in the atherosclerotic process. During inflammation,
arachidonic acid is released and metabolized by platelets to form thromboxane A2 which
causes platelet aggregation and adhesion. Activated platelets release pro-inflammatory
mediators and can inhibit the development of nitrous oxide and prostacyclin (69).
Aggregation of platelets can cause stenosis, impede blood flow and result in a thrombosis
(30).

Flavonoids have been implicated to affect multiple pathways and considered to
have antithrombotic and antiaggregatory properties. Youdim et al. concluded that
anthocyanins have implications in preventing vascular disease by protecting against
oxidative insult based on a study that demonstrated that vascular endothelial cells can
incorporate anthocyanins. Following a four hour incubation, anthocyanin extracts from
the elderberry were incorporated into the membrane and cytosol of endothelial cells (97).
In yet another study, Youdim et al. evaluated the antioxidant and anti-inflammatory
effects of blueberry and cranberry anthocyanins and hydroxycinnamic acids in human
endothelial cells. Berry phenols reduced up-regulation of inflammatory mediators and
responses to inflammatory insults (tumor necrosis factor a ) that result in the attraction of
leukocytes and endothelial damage. Furthermore, berry phenols were protective at the
endothelial cell membrane and cytosol against inflammatory insults, oxidative stress and
may be protective components in the development of vascular diseases (98).
Friesenecker et al. determined that flavonoids reduced the number of leukocytes adhering
to the endothelium during an arterial injury, which reduces the inflammatory response
(99). Tzeng et al. determined that flavonoids prevent thromboxane formation which
results in reduced platelet aggregation and adhesion (100). Numerous studies have
documented that flavonoids can also inhibit platelet aggregation by stimulating adenylate
cyclase activity (71).
Chung et al. evaluated the effect of quercetin and kaempferol derivatives on
platelet aggregation from various stimuli in the rabbit model. The results indicated that
both quercetin and kaempferol derivatives function to inhibit the platelet aggregation in
vitro (101). According to Melzig et al. kaempferol, a flavonoid found in blueberries, was

determined to prevent the action of deaminase, an enzyme responsible for adenosine
inactivation, in rat aortic endothelial cells (102). Zaragoza et al. determined through an
in vitro study examining the effects of the bilberry, that platelet aggregation was inhibited
by a solution of 30 mg/ml of bilberry anthocyanins (103). Bilberry contains four of the
five anthocyanins found in the whole wild blueberry. Freedman et al. evaluated the in
vivo and in vitro effect of purple grape juice and purple grape juice derived flavonoids

among 20 healthy male subjects with respect to cardiovascular disease and endothelial
integrity. The researchers discovered that platelet aggregation was reduced with the oral
supplementation and also during the in vitro trials. In addition, NO production was
increased and superoxide production was decreased in both trials. Therefore, positive
cardiovascular effects were observed both in in vitro and in in vivo studies with purple
grape juice (104). Thrombin-induced platelet aggregation and platelet activity in
thrombosis were decreased in rats fed grape polyphenolics (32). Numerous other in vitro
studies determined that anthocyanins reduce capillary permeability, prevent platelet
aggregation, and thrombus formation, which are all, associated with CVD (97, 98).
The antithrombotic and antiaggregatory activities of flavonoids are related to their
structure. Flavonoids' ability to inhibit platelet aggregation, by inhibiting CAMP, is
dependent upon the following: a double bond between C-2 and C-3, a 3-OH group, and a
carbonyl group at C-4. According to research conducted by Robak et al., flavonoid
glycosides and flavanone derivatives are not able to impair platelet aggregation.
Chemical characteristics that impede the ability of a flavonoid to effect platelet

aggregation are: saturation of the double bond between C-2 and C-3, glycosylation at C-3
and polyhydroxylation. Consequently, the inhibitory effects of flavonoids are determined
by the structural composition of the flavonoid (71).

2.5.3 Endothelium-dependent Vasorelaxation and Nitric Oxide
The vascular endothelium regulates vascular tone and blood flow through
responses to vasoactive stimuli and shear stress (105). Vasorelaxation assists in
preventing adhesion of platelets and reducing blood flow, which can affect the formation
of a lesion. The release of endothelium derived substances, including NO and EDHF,
produce endothelium dependent vasorelaxation. The reduced vasorelaxation observed
with a dysfunctional endothelium in various vascular pathologies is attributed to a
reduction in NO production and release (105). Thus, NO has been proven to play a
pivotal role in endothelial dysfunction (105, 106, 107).
Flavonoids from various fruits, vegetables, nuts, teas and herbs have been
implicated in inducing endothelium-dependent vasorelaxation through a variety of
mechanisms (105).

Andriambeloson et al. investigated the endothelial-NO dependent

effect of anthocyanin enriched blueberry extracts in vitro on rat aortic rings. The results
determined that the delphinidin, but not malvidin or cyanidin, enriched blueberry extract
induced an endothelial-NO dependent vasorelaxation. With endothelial removal or
suppression of NO synthesis via inhibitors, the relaxation mechanism was suppressed.
Consequently Andriambeloson et al. concluded that, the mechanism utilized in the
delphinidin-induced vasorelaxation was completely mediated by NO (105).
Andriambeloson et al. then observed the in vitro vasodilatory effect of red wine

polyphenolic compounds (RWPC) on NO induced vasorelaxation in rat aortic rings. The
RWPC induced endothelial-NO dependent vasorelaxation function by increasing the
production and release of NO and cyclic-guanosine 3', 5-monophosphate (1 06).
Andriambeleson et al, postulated that although flavonoids have been observed to reduce
the oxidation of lipids, the mechanism involved in RWPC induced vasorelaxation is
possibly based on the inhibition of cyclic nucleotide phosphodioesterase rather than on
the protection of NO from oxidative stress (106). Andriambeloson et al. also compared
the in vitro endothelium-dependent vasorelaxant activity of the individual RWPC
extracts, polymerized flavanols and anthocyanins of RWPC (105). Results of this study
revealed the anthocyanin extracts were more potent in inducing endothelium-dependent
relaxation than the oligomeric condensed tannins (105). In addition, the anthocyanin
delphinidin, an anthocyanin found in blueberries, was shown to induce 89% vessel
relaxation in vitro. On the hand, malvidin and cyanidin, two other anthocyanins found in
blueberries, did not induce vasorelaxation in vitro (105, 106). The endotheliumdependent vasorelaxation effect observed with the anthocyanin extracts and the
individual delphinidin extract was mediated entirely by NO and comparable to the effect
observed with the original RWPC (106). Fitzpatrick et al. observed in vitro NOendothelium-dependent vasorelaxation of the rat-precontracted aorta during exposure to
RWPC, grape juice polyphenolics and grape skin polyphenolics (107). Muzutani et al.
evaluated the in vivo effect of RWPC on blood pressure and the biomechanical properties
of stroke-prone hypertensive rats. The rats were fed RWPC for 8 weeks and Muzutani et
al. observed reduced blood pressure and improved arterial biomechanical properties
(108). In conclusion, the anthocyanin extracts, particularly delphinidin, of both RWPC

and blueberries, elicit endothelial-NO dependent vasorelxation in vitro in rat aortic rings
(105). Furthermore, these studies indicate the endothelial-NO dependent relaxation of
aortic rings is caused by an extracellular dependent calcium mechanism that activates NO
synthase. The vascular relaxation effect observed with polyphenolic compounds, with
respect to CVD, is most likely associated with the increases in NO production through
the NO-cGMP pathway and independent of their anti-oxidant effect (32, 105, 106, 107).
Lebeau et al. revealed encouraging results through an in vivo study in which rharnnoside
quercetin rich diets, reduced myocardial post-ischemic damage in rats (109). Tsuda et al.
fed rats cyanidin 3-0-P-D-glucoside (C3G) and observed an increased resistance to liver
ischemia-reperfusion injury. The C3G increased the serum thiobarbituric acid-reactive
substance (TBARS) indicating that C3G has in vivo antioxidant functions (1 10).
Djousse et al. examined the effect of red wine consumption with a high fat
meal on the postprandial endothelial function of 13 healthy human subjects by evaluating
flow-mediated dilation of the brachial artery. High fat meals may acutely impair
endothelium-dependent vasodilation. The results did not indicate a significant difference
in flow-mediated dilation with the consumption of red wine (1 11). Sanae et al. studied
the effects of eight catechin derivatives on the vascular tone of intact and denuded rat
thoracic aortas. The catechin derivatives were determined to inhibit the endothelium
dependent relaxation by inhibiting NO activation and impairing the response of guanylate
cyclase in VSMC. Consequently, Sanae et al. concluded that the catechin derivatives
potentiated the contractile response to phenylephrine observed in intact rat thoracic aorta,
and diminished the response in denuded rat thoracic aorta (1 12).

2.6 Cardiovascular Health and Whole Wild Blueberries
Blueberries, containing polyphenols and other antioxidants, have the highest
antioxidant capacity of all fruits and vegetables (48, 49). Numerous studies have
investigated the effect of polyphenolic extracts from flavonoid containing foods or the
activity of individual anthocyanin extracts. However, the vast majority of the studies
conducted thus far, has been in vitro or ex vivo, with only a few evaluating the effects of
anthocyanin extracts in vivo. In addition, there are very few studies that have evaluated
the role of whole wild lowbush blueberries (Vaccinium Angustfolium) in the etiology of
cardiovascular disease. Research on flavonoids implicates that flavonoids found in
blueberries could potentially improve vascular health by reducing platelet aggregation,
improving capillary permeability, reducing leukocyte adhesion and oxidative stress and
enhancing endothelial-NO dependent vasodilatation of the arteries (68).
Increased serum antioxidant status among human subjects following consumption
of lowbush blueberries (Vaccinium Angustfolium) has been documented. Kay et al.
investigated the effect of whole wild blueberries (Vaccinium Angustifolium) on
postprandial antioxidant status in humans as related to chronic degenerative diseases.
ORAC and total antioxidant status were used to evaluate the serum antioxidant status of
eight middle-aged men following a high fat meal and a control supplement and then a
high fat meal and a blueberry supplement. The blueberry supplement consisted of 100 g
freeze-dried blueberry powder. The results revealed that the blueberry supplement
caused a diet-induced increase in ex vivo serum antioxidant status (58). Kay et al.
observed an ex vivo increase in antioxidant status among eight human subjects following

a one week supplementation with 100 gramslday freeze dried blueberry powder (58).
Mazza et al. confirmed an increase in serum antioxidant status in five male subjects
following consumption of 100 g of freeze-dried blueberry powder (Vaccinium
Angustifolium) (1 13). Consequently, there is an association between the in vitro and
dietary ex vivo antioxidant properties of blueberries. According to Aviram et al. serum
antioxidant status and the development of chronic degenerative diseases are inversely
related (67).
Blueberries and red wine are obviously not the only dietary sources containing
anthocyanins. In fact, anthocyanins and polyphenolics found in numerous h i t s and
vegetables contribute to the concentrations of anthocyanins in human plasma. Studies
have been conducted to compare anthocyanin plasma values in humans with the plasma
concentration needed to induce relaxation. The effective concentration of plasma
anthocyanins required to induce 50% of maximal endothelium dependent relaxation
(E&), the ECso concentration, in humans is 1-10 pmol1L. Paganga and Rice-Evans
evaluated non-supplemented humans and found steady-state plasma concentrations of
anthocyanins to be 0.5-1.6 pmol1L (62). This observed anthocyanin plasma
concentration is within the EC50 value and implies that human plasma concentrations can
attain the amount needed to induce 50% of a maximal vessel relaxation. According to
Cao et al., peak serum antioxidant status in humans occurs 60 to 70 minutes following
consumption (1 14). Consequently, this evidence further enhances the possible
therapeutic role of dietary anthocyanins particularly those found in whole wild lowbush
blueberries (105).

Pilot studies in Dr. Klimis-Zacas's laboratory, as documented by Kalea et al. and
Norton et al. determined the effect of whole wild blueberries on the biomechanical
properties of the artery using the Sprague-Dawley rat model, as related to cardiovascular
disease (1 1, 1 15). They determined that blueberries added to the diet of Sprague Dawley
rats decreased the maximum contraction in response to alpha-1 adrenergic agonists in the
rat aorta. This is the first time whole wild blueberries incorporated into animal diets
showed an in vivo effect on the biomechanical properties of the arteries.
This research project is significant for two very unique reasons. One it is the first
time the role of dietary whole wild blueberries and their effects on the mechanical
properties of the arteries is being investigated. Hence, the study is one of the first in vivo
studies conducted to examine the health benefits of incorporating blueberries into a daily
diet. Second, this is one of the only nutritional projects worldwide utilizing the scientific
technology of tissue force analyzers to unravel a nutritional problem. The tissue force
analyzer is a highly sensitive and novel instrument being used in physiological
experiments. Tissue force analyzers allow us to relate the physiological properties of
arterial rings to their biomechanical properties. Consequently, this technology will allow
the effects of blueberries on the mechanical properties of denuded and intact arterial rings
to be studied as they relate to CVD.

2.7 Objectives
1. To evaluate the role of whole wild blueberries on the biomechanical properties (Fmax

and pDz) of the arteries of the Sprague-Dawley rat.
2. To determine the site of the action of whole wild blueberries on the artery (smooth

muscle vs. endothelium)

CHAPTER 3
MATERIALS AND METHODS

3.1 Animal Models

The experimental protocols and procedures for handling rats were approved by
The Institutional Animal Care and Use Committee of the University of Maine. Weanling
male Sprague-Dawley rats were obtained from the Charles River Laboratories
(Wilmington, MA). The animals were randomly assigned to one of three diet groups and
housed in conditions previously described (Taylor et al., 1996). The animals were
weighed weekly and provided with free access to food and tap water. The three diet
groups were the blueberry (B), AIN-93 control (C) and reverse (R) diet group. The B and
C group diet study were each fed for a period of 13 weeks. The R diet group consumed
the AIN-93 control diet for 13 weeks and then the blueberry diet for a period of 8 weeks.
Please refer to Table 3.1 for the Experimental Design of the Diet Study.

Table 3.1: Diet Groups
Diet Group Name

Diet Composition

Duration on Diet

Control Group

AIN-93 diet

13 weeks

Blueberry Group

AIN-93 diet plus blueberries

1 Reverse Group

I AIN-93 diet

I AIN-93 diet plus

blueberries

/1
1

l 3 weeks
13 weeks
8 weeks

3.2 Diet Composition

Diet composition is presented in Table 3.2. The diets were composed of dextrose,
egg white solids, vitamin mix, D-L-Methionine, biotin, mineral mix (lgmlkg), and corn
oil. All purified ingredients were purchased from Harlan Teklad (Madison, WI), with the
exception of the mineral mix that was purchased from ICN Biomedicals (Aurora, OH).
Whole wild bluebemes were purchased as a composite of bluebemes from Wymans
(Cherryfield, ME) and freeze dried with standard procedures by the American
Lyophilizer Inc. (Bridgeport, PA). A blender was used to grind the freeze dried
bluebemes to a fine powder. Food intake among diet groups did not differ as determined
by Kalea et al. (1 1).

Table 3.2: Diet Composition
Dietary Component

Control Diet

Blueberry Diet

Dextrose

691 g

61 1g

Egg white solids

200 g

200 g

Blueberries

og

80 g

Vitamin mix

10 g

10 g

D-L-Methionine

4g

4g

Biotin
Mineral mix (1g/kg Mn)

Total

1

0.002
35 g

1000 g

1000 g

3.3 Drugs and Solutions for the Surgical Procedure

Salts for the Physiologic Salt Solution (PSS in rnM: NaCl 118, KC1 4.7, CaC12.5,
MgS04 1.2, KH2P041.2, NaHC03 12.5, glucose 1 1.I), acetylcholine chloride and Lphenylephrine were purchased from Sigma (St. Louis, MO, USA).

3.4 Preparation and Mounting of Rat Aortic Rings

At the end of the feeding period, each animal was fasted for 10-12 hours prior to
the beginning of each experiment. Each animal was sacrificed with the administration of
2 to 3 minutes of C 0 2 anesthesia. Blood was removed via cardiac puncture and the
thoracic aorta was carefully extracted and placed in PSS. The aorta was then measured in
a silicon-coated petri dish containing a ruler fastened to the bottom. The adhering fat and
connective tissue were carefully removed from the vessel. The shape, length and any
abnormalities of the aorta were documented. The vessel was cut into four rings, each 2-3
mm in length using surgical scissors (George Tiemann & Co., Hauppauge, NY). With
each animal, two of the rings were denuded and two were left intact for the experimental
procedure.
Denudation was achieved in two of the four aortic rings by gently rubbing the
intima of the aortic ring with curved forceps on a PSS saturated paper towel. Figure 3.1
illustrates the method utilized to achieve denudation. Denudation mimics the arterial
injury that occurs in CVD. Furchgott and Zawadzki utilized the denudation method to
discover the role, mechanism and factors influencing the pathway of EDRF/NO (1 16).
These researchers determined that rabbit aortic vessels with an intact endothelium relaxed
in the presence of acetylcholine.

Figure 3.1: Method Used for Denudation

Ring

Endothelium removal

Excerpted from Luscher & Vanhoutte (9).

Whereas denuded aortic rings were not able to relax in the presence of EDRF/NO
because the EDRF is released from the endothelium which is absent in denuded rings
(1 16). In an intact endothelium, the contractile response of the a-adrenoreceptor is
reduced because of the effect of NO to induce vasodilation (1 17). Disturbances in the
production of EDRF/NO are commonly observed in atherolsclerotic animal models
because of the presence of a dysfunctional endothelium. Consequently, the role of whole
blueberries as a functional food, with respect to CVD, can only be evaluated and fully
understood through an in vivo study investigating both intact and denuded arterial rings.
The rings were passed through two stainless steel wires that were closed upon
themselves to form two wire triangles (16, 117). The aortic rings were mounted in
standard organ tissue baths containing PSS aerated with 95%02 15% C 0 2 (pH 7.45) and
maintained at 37'C by a thermoregulator (16,20). One of the triangles was connected to
a wire attached to a microprocessor based Tissue Force Analyzer (Micro-Med,
Louisville, KY) while the other wire was attached to a glass hook in the tissue bath. The
order the rings were placed in tissue baths was random. All rings from each animal were
mounted in organ baths within 75 minutes from the administration of the anesthesia.
The experimental design in its entirety is diagrammed in Figure 3.2.

Figure 3.2: Experimental Design
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3.5 Tissue Equilibration and Experimental Protocol
Following a 45 minute equilibration period under a 1.5 gram preload rings were
preconditioned with the 17p1 of acetylcholine (Ach)

and 17p1 of L-Phenylephrine

(Phe) 10-3for a period of 10 minutes followed by five washouts. Contraction of the rings
was accomplished with six progressively higher doses of the alpha-1-adrenergic receptoragonist Phe

to 3 x lo-'). Administration of acetylcholine (3 x

induces

relaxation and was utilized to validate the presence or absence of an endothelial layer
among the rings. Following a 25 minute wash out period a second Phe dose response
curve was generated as previously described (1 1).
The percent relaxation for each ring was assessed with the administration of the
Ach dose. The exclusion criteria for the condition of the endothelium were determined
by the percent relaxation observed in intact and denuded rings. Arterial rings with an
intact endothelium demonstrated a relaxation between 85% and 100%. Intact arterial
rings were excluded and considered to have a damaged endothelium if they relaxed less
than 85%. Arterial rings without an endothelium did not show more than a 5%
relaxation. Denuded arterial rings that exhibited an endothelium induced relaxation
greater than 5% were excluded and determined to not have been successfully denuded
(11, l6,2O, 117).
Tension changes in the artery assessed by the tissue force analyzers were
measured by a personal computer with system integrated software to generate digitalized
raw data (DMSI-210, Micro-Med, Louisville, KY ). The digitalized raw data was used to
generate individual dose response curves and the experimental parameters. The
experimental parameters are presented in Table 3.4. Contraction and relaxation

generated tension changes were used to generate the maximum contraction force (Fmax)
value. The Fmax is indicative of the myogenic behavior and mechanical properties of
each aortic ring and was used to determine the effect of the diet on the contractile
machinery of the artery. ECso is the concentration of the fraction required to inhibit 50%
of the vessel response. The ECso was obtained by transforming the dose response curves
to semi-log curves. The pD2 value indicated the vessel sensitivity to each fraction of
agonist added to the tissue bath. The pD2 value was calculated as the negative log (base
10) of the EC50value and serves as an indicator of receptor agonists interactions (1 6,
1 17).

Table 3.3: Experimental Parameters
Experimental Parameter

Biological Interpretation

Assessment Method

Fmax

Maximum contraction and
relaxation force of the
vessel
Contractile machinery

Dose response curve

Cell membrane receptor and Negative log of ECso
vessel reactivity
Vessel reactivity
Ach dose required to inhibit
50% of vessel response

Semi-log transformations

3.6 Statistical Analysis
The Sigmastat Statistical Program Package (SAS Institute, Cary, NC) was used to
conduct the statistical analysis. The values for Fmax and PD2 were presented as the mean

* SE. The Fmax and PD2 value were each compared between diet groups with separate
two-way analysis of variance (ANOVA) to detect the effect of diet. A three-way
ANOVA was used to assess the differences between the intact and denuded rings with
respect to different dietary treatments and the Student Newman Keuls (SNK) was used
for multiple comparisons. Comparisons among animal body weights were conducted
with standardized T-tests. Statistical significance was defined as a P value <0.05 (1 1, 16,
20).

CHAPTER 4
RESULTS

4.1 Rat Growth and Weights
Figure 4.1 displays the rat growth curve. Animals on the B, C, and R diets all
gained weight during the diet study. The rate of growth did not show a significant
difference between the groups during the 13 week time period. The final mean body
weights at the end of the 13 week period were 5 13
the B group and 508

* 1 l g for the C group, 522 * 7g for

* 9g for the R group. The final mean body weights between the

three groups did not differ significantly at the end of the 13 week period @<0.05).
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4.2 Food Consumption
The daily food intake among animals on a C, R and B diet was evaluated in the
pilot study conducted in our laboratory during the previous year (1 1). Food intake per
day did not differ significantly among diet groups over the course of the 13 week study.
For the three groups, food intake steadily increased during the first five weeks and then
steadily plateaued. No statistically significant differences were found in food intake
among the three diet groups (See figure 4.2).

Figure 4.2: Effect of Whole Wild Blueberries on Food Intake of Sprague-Dawley
Rats
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4.3 Maximum Contraction Force (Fmax Value)
4.3.1 Denuded and Intact Arterial Rings Maximum Contraction Force
The mean maximum contraction force (Fmax) was evaluated in the denuded and
intact arterial rings of all three diet groups and is presented in Table 4.1. The maximum
contraction force that developed in response to phenylephrine was significantly different
between the denuded and intact arterial rings. The intact arterial rings developed a
significantly smaller contractile response, while the denuded arterial rings developed a
larger contraction force (p<0.05) in response to phenylephrine. Mean Fmax among the
intact arterial rings of the three diet groups was 0.969 h 0.00781 ; while among denuded
arterial rings mean Fmax was 3.076 =k 0.00781 with statistically significant differences at
~~0.05.

Table 4.1: Effect of Denudation on the Mean Maximum Contraction Force (Fmax)
of Arterial Rings
Arterial Ring Treatment

Fmax Value (grams)

Intact Arterial Rings

0.969 =k 0.0078 1'''

Denuded Arterial Rings

3.076 h 0.00781'~'
I

I

(1) (2) Means between groups not having the same number are statistically significant at
p<0.05.

4.3.2 Intact Arterial Rings Maximum Contraction Force
The effect of the diet on intact and denuded rings is presented in Table 4.2. The
mean maximum contraction force that developed among the intact arterial rings of the
control group was significantly larger than the mean maximum contraction force that
developed among the intact rings of the blueberry and reverse groups ( ~ ~ 0 . 0 5The
).
mean Fmax observed among the control group's intact arterial rings (1.109 i 0.0463)
was significantly different than the mean Fmax observed in the intact rings of both the
reverse (0.926

* 0.0463) and blueberry (0.873 * 0.0463) groups ( ~ ~ 0 . 0 5 Thus,
).
the

intact arterial rings of the blueberry and reverse groups developed a significantly smaller
contraction force when challenged with the L-phenylpherine compared to the control
group (p<0.05). Additionally, the Fmax of the blueberry group's intact arterial rings
tended to be lower than the reverse group's intact arterial rings but did not reach
statistical significance (p<0.05). Figure 4.3 graphically depicts the mean maximum
contraction force of the intact arterial rings.

Table 4.2: Effect of Whole Wild Blueberries on the Mean Maximum Contraction
Force (Fmax) of Intact Arterial Rings

1 Diet Group
Control Group
Blueberry Group
Reverse Group

I Fmax Value (grams)
1.109 * 0.0463
0.873 * 0.0463 "'
0.926 * 0.0463 "'
'I'

(1) (2) Means between groups not having the same number are statistically significant at
p<0.05.

Figure 4.3: Effect of Whole Wild Blueberries on the Mean Maximum Contraction
Force (Fmax) of Intact Arterial Rings
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BControl
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*Statistically significant at p<0.05.

4.3.3 Denuded Arterial Rings Maximum Contraction Force

The mean Fmax of the denuded arterial rings from the blueberry, control, and
reverse diet groups are presented in Table 4.3. The mean Fmax developed by the
denuded arterial rings of the control, blueberry and reverse groups were 3.065

* 0.0580,

3.185 h 0.0580 and 2.977 h 0.0580 respectively. No statistically significant differences
in Fmax among the denuded arterial rings were observed (p<0.05). Figure 4.4 presents
graphically the effect of diet on the Fmax of denuded arterial rings.

Table 4.3: Effect of Whole Wild Blueberries on the Mean Maximum Contraction
Force (Fmax) of Denuded Arterial Rings
Diet Group

Blueberry Group

1 Reverse Group

Fmax Value (grams)

* 0.0580
1 2.977 * 0.0580
3.185

Means are not statistically significant at p<0.05.

Figure 4.4: Effect of Whole Wild Blueberries on the Mean Maximum Contraction
Force (Fmax) of Denuded Arterial Rings

Not statistically significant at ~ ~ 0 . 0 5 .

I

4.4 Vessel Sensitivity: pD2 Values
4.4.1 Denuded and Intact Arterial Rings Vessel Sensitivity
The pD2value is a measure of vessel sensitivity to the alpha-adrenergic receptor for each
phenylephrine dose. Vessel sensitivity indicates the membrane receptor conformational
changes that occurred for each phenylephrine dose. Table 4.4 presents the pD2values for
the intact and denuded arterial rings. The pD2value for the denuded arterial rings (7.471

* 0.00451) was significantly higher than the pD2value for the intact arterial rings (6.776
* 0.00451) at p<0.05.

Table 4.4: Effect of Denudation on the Mean pD2 of Arterial Rings
Arterial Ring Treatment
Intact Arterial Rings
Denuded Arterial Rings

1 Vessel Sensitivity: pD2 Value
* 0.00451"'
7.471 * 0.0045 1'2)

6.776

(1) (2) Means between groups not having the same number are statistically significant at
p<0.05.

4.4.2 Intact Arterial Rings Vessel Sensitivity
Table 4.5 and Figure 4.6 display the mean pD2values observed among the intact arterial
rings. The mean pD2values for the intact arterial rings of the blueberry (6.751
control (6.715

* 0.0791),

* 0.0791) and reverse (6.864 * 0.0791) diet groups did not differ

significantly from each other (p<0.05) .

Table 4.5: Effect of Whole Wild Blueberries on the Mean pD2 of the Intact Arterial
Rings
Diet Group

Vessel Sensitivity: pD2 Value

Control Group

6.715 i 0.0791

Blueberry Group

6.751

Reverse Group

6.864 i 0.0791

I

* 0.0791

I

Means are not statistically significant at p<0.05.

Figure 4.5: Effect of Whole Wild Blueberries on the Mean pD2 of Intact Arterial
Rings
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4.4.3 Denuded Arterial Rings Vessel Sensitivity
Table 4.5 and Figure 4.6 display the mean pD2values observed among the denuded
arterial rings. The mean pD2values for the denuded arterial rings of the blueberry (7.548

* 0.0509), control (7.426 * 0.0509) and reverse (7.440 * 0.0509) groups did not differ
significantly from each other (p<0.05).

Table 4.6: Effect of Whole Wild Blueberries on the Mean pD2 of Denuded Arterial
Rings
Diet Group

Vessel Sensitivity: pD2 Value

Control Group

7.426

I Blueberry Group
Reverse Group

* 0.0509

1 7.548 * 0.0509
7.440

Means are not statistically significant at p<0.05.

* 0.0509

I

62

Figure 4.6: Effect of Whole Wild Blueberries on the Mean pDz of Denuded Arterial
Rings
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Not statistically significant at p<0.05.
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CHAPTER 5
DISCUSSION

5.1 Overall Results
The objective of the present study was to evaluate the in vivo dietary effect of
whole wild blueberries on the biomechanical properties of the Sprague-Dawley rat aorta
as related to cardiovascular disease. Our results demonstrate for the first time that whole
wild blueberries affect the vascular contractile machinery causing a decrease in the mean
maximum contraction force (Fmax) in response to the contractile effect of the alpha-ladrenoreceptor agonist L-phenylephrine (PE). These results indicate that blueberries
require a functional endothelium to exert their effect on the vascular contractile
machinery. However, based on the results from vessel reactivity index, pD2, blueberries
most likely do not function through cell membrane receptor-agonist interactions. The
effect of blueberries to improve arterial integrity, decrease vasoconstriction and reduce
vascular resistance has implications for blood pressure regulation and overall
cardiovascular health. Cardiovascular disease (CVD) continues to claim more lives each
year in developed countries than any other disease. An alarming fact is that, only 30% of
the morbidity associated with CVD can be attributed to the traditional risk factors.
Consequently, the observed cardiovascular benefit of whole wild blueberries could
provide a therapeutic mechanism for the maintenance of arterial health and the prevention
of a dysfunctional endothelium.
The endothelium plays a central role in the pathogenesis of cardiovascular disease
(5, 8). By modulating the arterial damage when individuals are exposed to stress or risk

factors for atherosclerosis. Endothelial dysfunction, one of the earliest stages in
atherosclerosis, impairs the release and action of vasoactive substances and precedes the
morphological changes of the arterial wall (8, 9). The dysfunctional endothelium, created
by mechanically removing the intima, mimics the endothelium damage that occurs with
atherosclerosis. The alpha-adrenergic receptors of the endothelial cells produce
vasoconstrictor and vasorelaxing factors in response to stimuli (1 17). Vasoacitve
substances produced by a functional endothelium exert their action on the VSMC or the
endothelium to elicit a contraction or relaxation. Consequently, Kawabe et al. proposes
that the alpha-adrenergic receptors may allow for endothelial cell regulation of the
VSMC contraction (1 17). VSMC regulation via the alpha-adrenergic receptors could
prevent complete closure of the vasculature (1 17). The endothelium is also critical for
the vessel relaxation induced by other vasoactive substances including bradykinin,
substance P, histamine, serotonin and arachidonic acid (12).
The role of denudation is to remove the functional endothelial layer responsible
for the production of vasoactive substances. A dysfunctional endothelium is unable to
modulate the balance of endothelium-dependent vasorelaxation and contraction that is
required to maintain vascular integrity (5, 9). Thus the effect of denudation allowed us to
elucidate where blueberries act to affect the VSMC or the endothelium of the artery.
Impairment of endothelium-dependent NO arterial relaxation occurs with a
dysfunctional endothelium in the early stages of atherosclerosisis (1 18). Nitric oxide, a
vasodilator, functions to inhibit VSMC contraction. Thus, a possible physiological
influence of NO includes regulating blood pressure by affecting vasoconstriction of the
vessel (22). The endothelial-dependent vasorelaxation, stimulated by increases in the

CAMP-NO system is impaired with a dysfunctional endothelium.

Thus, the

bioavailability of NO may be responsible for the impaired VSMC function that occurs
with a dysfunctional endothelium (16, 117). Numerous studies have documented the
beneficial effects of NO, including: vasodilation, inhibition of vasoconstriction, inhibition
of platelet adhesion, inhibition of leukocyte adhesion, reduction of smooth muscle cell
proliferation, and the scavenging of superoxide anions (9, 12,43). Therefore, reduced
NO production, occurring with a dysfunctional endothelium, is instrumental in the
progression of cardiovascular disease.

5.2 Effect of Denudation
The effectiveness of denudation was evaluated with the effect of acetylcholine on
each arterial ring. Furchgott and Zawadzki determined that acetylcholine requires the
endothelium to cause arterial vasorelaxation (1 16). Thus, endothelial denudation was
confirmed with the application of an acetylcholine dose and subsequent lack of vessel
relaxation. In our study, the denuded arterial rings had an increased maximum
contraction force (Fmax) compared to the intact rings. The observed contractile ability of
the denuded rings' VSMCs indicates that the integrity of the contractile machinery was
not compromised during the mechanical denudation procedure. In addition, the denuded
rings displayed less than 5 % relaxation upon exposure to the acetylcholine dose. Our
results are in agreement with Adeagbo et al. who observed acetylcholine-induced
relaxation of intact rings and no relaxation among the denuded rings (27). Acetylcholine
exerts its effect through an indirect mechanism involving endothelium derived relaxing
factor (NO) that diffuses from the endothelium to the VSMC (16). In addition,

acetylcholine mediated vasodilation can occur through NO, PGI2, and EDHF (1 17). Our
results validate that our denudation procedure effectively removed the endothelial layer
of the denuded arterial rings without damaging the VSMC layer.
In our animals, the maximum contraction force (Fmax) developed in response to
L-phenylephrine agonist was increased among the animals with denuded arterial rings
compared to animals with intact arterial rings. The effect of denudation increases the
concentration of receptor sites available for alpha- 1- agonists binding (27). Thus the
absence of the endothelium enhances the contraction, via binding of L-phenylephrine to
VSMC alpha-1 -adrenoceptors (1 19). The structural integrity of the denuded rings was
confirmed with the expected absence of relaxation upon application of an acetylcholine
dose. It has been known for some time that endothelium-derived nitric oxide (NO)
mediates vascular relaxation (27). Endothelial dysfunction impairs the production and
release of endothelium-dependent vasodilating substances (i.e NO) to cause vessel
relaxation. Thus the endothelium-denuded vessels prevented the endothelium from
functioning as a modulator of vasoconstriction and vasodilation (1 18). As expected, we
observed a reduced Fmax to PHE among the endothelium-intact arterial rings. The
presence of a functional endothelium among the intact rings, reduces the concentration of
receptor sites for PHE to bind, because the endothelial layer lines the vessel and prevents
direct exposure of the VSMC to the agonists.
Vessel reactivity, pDz,is an index of membrane receptor agonist interactions
which in this study indicates whether bluebemes act to affect the pathway of the agonist.
Vessel reactivity is derived from the ECSo. The ECso is the concentration of the agonist
fraction required to inhibit 50% of the vessel response. The ECso was obtained by

transforming the dose response curves to semi-log curves (120). The pD2 value was
calculated as the negative log (base 10) of the EC50 value and serves as an indicator of
receptor agonists interactions and vessel sensitivity to each fraction of agonist added to
each tissue bath. As expected, differences were observed in the pD2 value between
intact and denuded arterial rings (1 17). The reduction that we observed in the pD2 of
intact arterial rings suggests a depressed membrane-related effect of receptor agonist
interactions. The observed increased pD2 value of denuded arterial rings occurs because
of the increased receptor-agonist interactions occurring in the absence of the endothelial
cell layer (16, 117). With the removal of the endothelium, agonist receptors on the
VSMC are exposed and present in a higher concentration which allows an increased
binding and action of agonists.

5.3 Effect of Diet
This is the first study to document the in vivo effect of whole wild blueberries on
the biomechanical properties of the artery of Sprague-Dawley rats. Among the intact
arterial rings, blueberries decreased the Fmax to PHE when compared to their effect on
the control animals. The differences in Fmax between the blueberry and control group's
intact arterial rings indicate that blueberries function on the vascular contractile
machinery of the artery. Our results also demonstrated for the first time a reduced
maximum contraction force to PHE between the intact rings of the reverse and the control
diet groups. This suggests that the addition of blueberries to older animals may be
beneficial in maintaining endothelial function and regulating vascular tone. The reverse
diet group consisted of animals consuming the control diet for thirteen weeks and then

the blueberry diet for eight weeks. Additionaly, there were no differences in the
maximum contraction force to PHE between the blueberry and reverse diet groups.
Consequently, these results indicate that blueberries can function to reduce the maximum
contraction force to PHE among animals that had previously consumed a diet without
blueberries. Our results suggest that blueberries require a functional endothelium in
order to affect the biomechanical properties of the aorta. In addition, the present study
indicates that blueberries could function to not only maintain but also to improve arterial
integrity of older animals.
Our results are supported by the in vitro observation that blueberry extract,
enriched with anthocyanins, functioned to cause endothelial-NO dependent relaxation of
the rat aorta (12 1, 105). Even though our results are the first to evaluate dietary
consumption and the corresponding effect of whole blueberries on arterial function, other
anthocyanin containing foods have been evaluated. The effects of red wine polyphenolic
compounds (RWPC) on endothelial function have received considerable attention by
researchers. Andriambeloson et al. observed the in vitro effect of red wine polyphenolic
compounds (RWPC) on the endothelium to induce endothelium-dependent
vasorelaxation (106).

Andriambeloson et al. concluded that the effect of RWPC to

induce vasorelaxation is associated with an enhancement of the NO-cGMP system rather
than the ability of RWPC to protect NO from breakdown (105, 107). In addition, redwine improved arterial health by preventing homocysteine from decreasing eNOS levels
and resulting in endothelial dysfunction (121).
We did not observe differences in the vessel reactivity (pDz) of the intact arterial
rings between the control, reverse or blueberry groups. This suggests that the ability of

the blueberry diet to affect the vascular tone of the artery does not involve interactions
between agonist membrane receptors and blueberry components. In addition, there were
no differences among the denuded arterial rings from the different diets that affected the
membrane-receptor agonist interactions. These results further suggest that the effect of
blueberries does not involve membrane-receptor agonists on the VSMC.
Most likely, bluebemes' effect of the vascular contractile machinery requires the
presence of a functional endothelium, as indicated by differences in Fmax, but does not
involve membrane-receptor agonist interactions on the endothelium or VSMC. Our
results suggest for the first time that whole wild blueberries, as a component of the diet,
may be capable of improving the arterial integrity by affecting the vascular contractile
machinery of the artery when challenged with PHE.

An effect of diet was not observed among the denuded arterial rings from the
three dietary groups. Hence, the observed maximum contraction force and vessel
reactivity of the endothelial-denuded arterial rings from the blueberry, control, or reverse
diet groups were not significantly different. As previously stated, differences were
observed in vessel reactivity between the intact and denuded rings within each diet group.
Thus, the mechanism by which bluebemes elicit an effect on the aortic VSMC contractile
machinery to improve arterial integrity requires the presence of a functional endothelium.
These results indicate that although bluebemes do not have membrane-related effects of
receptor-agonist interactions, they function through a pathway in the endothelium to
ultimately affect the vascular contractile machinery of the artery. Thus the mechanism by

which blueberries may act to reduce arterial contraction in response to alpha-1 -adrenergic
agonist could occur through a pathway such as NO or CAMPthat requires an intact
endothelial layer.

5.4 Blueberry Components

This is the first time an in vivo effect of diet with whole wild blueberries on the
endothelium has been observed. Previous studies have evaluated the in vitro effect of
both blueberry and other polyphenolic components on endothelial function. Potentially,
the polyphenolic components eliciting the vessel relaxation may also function to reduce
the vessel contraction by preserving NO. Of the 17 known anthocyanins, only 6 are
found in higher plant forms and 5 of these anthocyanins are found in the blueberry. The
five anthocyanins identified in whole wild blueberries, delphinidin, malvidin, petunidin,
cyanidin and peonidin, are shown in figure 2.3 and table 2.2 (54, 122). The results of our
dietary study indicate the in vivo effects of the whole wild blueberry on the endothelium.
On the other hand, previous studies evaluated the in vitro beneficial cardiovascular effect
of individual anthocyanin extracts from blueberries and other polyphenolic containing
foods. RWPC extracts, malvidin and cyanidin did not induce endothelium-dependent
relaxtion, while delphinidin induced endothelial vasorelaxation was completely mediated
by NO (105). The location of the hydroxyl group on the anthocyanin may influence its
antioxidant and antiproliferative activity (71). Consequently, the hydroxyl group position
may also influence its ability to induce endothelial vasorelaxation (123). The increased
synthesis of NO observed by Andriambeloson et al. may partially explain how
polyphenolic compounds of whole wild blueberries in our study reduced vasocontraction.

However, the results we observed reflect the bioavailability of the whole wild blueberry
in addition to the synergistic effects of its components on the endothelium.
The in vitro cardioprotective mechanism of polyphenolic compounds may be
associated with the elicited endothelial NO dependent relaxation. Peroxynitrite is a toxic
oxidant, formed from the reaction of NO and superoxide anion. Cyanidin-3-0-glucoside
(C3G) extract from blackberries, displayed an in vitro protective effect against
endothelial dysfunction by scavenging peroxynitrite in human umbilical vein endothelial
cells (124). Therefore, cyanidin-3-0-glucoside may be capable of improving the
bioavailability of NO. Enhanced endothelial NO-synthase-mediated relaxation was
observed in internal mammary aortic rings following pre-incubation with procyanidins
from grape seed extract. The procyanidins protected the endothelial cells from
peroxynitrite damage and increased endothelium-dependent relaxation. Thus, this study
supports the possibility that structurally related anthocyanin compounds affect the NO
and influence the endothelium (125).
Intact aortic rings exposed to RWPC displayed an increase in cGMP formation
(106). Delphinidin produced the same profile as the RWPC and is also one of the five
anthocyanins in blueberries (54, 105). The possible role of the involvement of the NOcGMP system is reinforced by the fact that blueberry extracts enriched with anthocyanins
caused an NO-endothelial dependent relaxation of rat aorta (106). The effect of
anthocyanins on the NO is further evidenced by the ability of anthocyanins to increase
the activity of NO synthase and cause relaxation of the aortic rings (107). Thus,
blueberries act on the endothelium to affect a pathway in the VSMC possibly by affecting
the NO-cGMP system.

5.5 Hypothetical Mechanism

The results of our in vivo study are reinforced by the in vitro observations
previously stated. Although the beneficial cardiovascular mechanism of whole wild
blueberries is unknown, endothelium-dependent vasocontraction and vasorelaxation may
be attributed to the enhanced synthesis of NO. We hypothesize that a mechanism
involving enhanced NO production or increased NO bioavailability may be responsible
for the reduced maximum contraction force observed among the blueberry groups intact
rings in our study. The pathway for NO production, as depicted in Figure 2.2, involves
the guanylate cyclase catalyzing the formation of cGMP. Increased formation of cGMP,
causes smooth muscle relaxation via protein kinase phosphorylation. Continued stimulus
of the endothelial cells may increase in cGMP and cause a relaxation response of the
VSMC (107). Nitric oxide functions to activate VSMC guanylate cyclase, produce
CAMP,cause vasodilation locally and may also be deactivated by superoxide and other

02free radicals (12). Red wine increased endothelial NOS activity in human endothelial
cells in vitro (126). Duarte et a1 investigated the effect of flavonoids on rat aortic smooth
muscle and revealed that a possible mechanism of flavonoids involved the reduction of
cGMP breakdown by inhibiting cyclic nucleotide phosphodiesterases (127). Activation
of phsopholipase C, phospholipase A, protein kinase C, and tyrosine kinase are not
involved in the endothelial NO-dependent vasorelaxation induced by wine polyphenols in
the rat thoracic aorta (128). Nitric oxide bioavailability is based upon intracellular
availability of L-arginine, altered NOS activity (eNOS or iNOS), impaired receptor
mediated release of NO and generation of reactive oxygen species (12). Thus, the
preservation of NO or increased production of NO may occur through several

mechanisms and affect the contractile machinery of the VSMC. The increased
bioavailability of NO could be responsible for the effect of whole wild blueberries on the
endothelium.
Numerous studies have documented the absorption and metabolism of
anthocyanins from the blueberry to increase the serum antioxidant status (58,63, 113).
The absorption of polyphenols by human subjects was detected by Paganga and RiceEvans to increase polyphenolic plasma concentration to 0.5-1.6 pmol. The plasma
concentration detected was comparable to the polyphenolic concentration required to
induce 50% of the vessel maximal relaxation (62). Youdim et al. determined that
anthocyanins extracted from the elderberry can be incorporated into the endothelial cell's
cytosol and membrane to enhance resistance to reactive oxygen species in vitro (97).
These studies confirm the absorption and incorporation of anthocyanins in humans and
suggest the bioavailability of anthocyanins allows a concentration to provide an in vivo
effect. Furthermore, based on these studies on absorption and incorporation of berry
anthocyanins, we hypothesize that the effect of whole wild blueberries observed in the
Sprague-Dawley rat aorta may also be observed in humans to improve arterial integrity
and possibly cardiovascular function.

5.6 Clinical Relevance
Blueberries and other polyphenolic containing fruits have been recognized as
having various health benefit's in protecting against chronic diseases including;
preventing glaucoma, fibrocystic disease of the breast in humans, cancer, cerebrovascular
conditions, diabetes, atherosclerosis, and cardiovascular disease (30). Blueberries have

the highest polyphenolic content of all fruits and vegetables (48,49). Investigators have
also observed a direct correlation between polyphenolic content and antioxidant
properties of blueberries (48,49). Our results confirm that whole wild blueberry
components are bioavailable and can elicit an in vivo effect on endothelial function. The
present study indicates that blueberries aid in arterial relaxation by acting on the
vasodilator tone of the artery. In addition to improved vasorelaxation, studies have
documented blueberries and blueberry component benefits on the cardiovascular include;
reduced capillary permeability, decreased platelet aggregation and leukocyte adhesion,
increased arterial flexibility, inhibition of oxidation and Maillard reactions and reduced
inflammation (68). Thus far, blueberries have been implicated to be beneficial in
preventing the progression of atherosclerosis and for improving cardiovascular health
through various mechanisms. The vast majority of studies have been conducted in vitro.
Hypertension (high blood pressure) is a known risk factor for the development of
atherosclerosis. The arteries of hypertensive individuals have increased vascular tone,
increased vasoconstriction and a reduced a vascular response to sheer stress (129).
Pomegrantate juice was shown to have an inhibitory effect on serum angiotensin
converting enzyme (ACE) levels and to slightly reduce the blood pressure of
hypertensive patients after two weeks of consumption (130). Our results indicate that
blueberries act through NO to affect the vascular tone of the artery. The vasorelaxant
effect that blueberries appear to be capable of elliciting in arteries could have
implications on blood pressure regulation. Furthermore, whole wild blueberries could
have therapeutic implications for blood pressure regulation.

5.7 Conclusion
This is the first study to identify the role of whole wild blueberries and the
location of their effect on the vascular endothelium. In addition, this is the first dietary
study evaluating the possible implications whole wild blueberries could have on
endothelial function as related to cardiovascular disease. Our results confirm that
sufficient absorption of the whole blueberries occurred to create an in vivo effect. This
study determined that whole wild blueberries affect the vascular contractile machinery of
the rat aorta to reduce the maximum contraction force generated in response to the alpha1-adrenergic agonist L-phenylephrin in vivo. Blueberries do not affect vessel reactivity

as indicated by the pDz value. They seem to act on the VSMC through the endothelium
and may involve the NO-cGMP system. Our results indicate that blueberries can
improve arterial integrity and alter the responsiveness of the artery to factors such as high
blood pressure or other factors increasing vessel contractility and predisposing the
cardiovascular system to CVD. This suggests that blueberries improve the vascular tone
of the artery. Consequently, whole wild blueberries may have implications in blood
pressure regulation and could prove to have a therapeutic role in improving
cardiovascular health.

5.8 Limitations and Future Recommendations
The majority of studies conducted thus far on the vasorelaxant benefits of
polyphenolic compounds with reference to cardiovascular health have focused on RWPC.
Although blueberries and red wine have a similar polyphenolic profile they do have
significant differences. This study served the purpose of identifying the location of the

action of blueberries on the artery and allowed us to speculate the mechanism of
blueberries action involving NO to be proposed. Further studies are needed to identify
the pathways that whole wild blueberries functionto affect the contractile machinery of
the aorta. Studies are also needed to elucidate the dietary effectiveness of individual
blueberry extracts in comparison to the dietary effect of whole wild blueberries on the
aortic vascular contractile machinery. For instance, delphinidin, an anthocyanin common
to red wine and blueberries, was documented as producing a vasorelaxant effect
comparable to red wine. It is unknown if the benefit of the whole blueberry or what
combination of polyphenolic compounds or individual anthocyanins are responsible for
the vasorelaxant effect observed in this study. In addition, studies in other animal models
are required to evaluate the dietary effect of whole wild blueberries on the endothelium
and VSCM. An investigation should also be conducted to evaluate the possible role of
whole wild blueberries on blood pressure regulation. The hypertensive rat would be an
ideal model to evaluate the dietary effect of whole wild blueberries on blood pressure
regulation. Another study would be to evaluate the effect of whole bluebemy
consumption within a population of hypertensive human subjects. It is apparent that
based on our in vivo observations; there are numerous avenues a researcher could select
to better understand the pathway blueberries utilize to affect the endothelium as related to
cardiovascular health. Hopefully, the consumption of whole wild blueberries will prove
to be an alternative therapeutic modality for improving endothelial function and overall
cardiovascular health.
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